GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Cyclezyme AB (XSAT:CYCLE) » Definitions » Debt-to-Equity

Cyclezyme AB (XSAT:CYCLE) Debt-to-Equity : 0.07 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Cyclezyme AB Debt-to-Equity?

Cyclezyme AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was kr0.04 Mil. Cyclezyme AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was kr0.46 Mil. Cyclezyme AB's Total Stockholders Equity for the quarter that ended in Dec. 2023 was kr6.88 Mil. Cyclezyme AB's debt to equity for the quarter that ended in Dec. 2023 was 0.07.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Cyclezyme AB's Debt-to-Equity or its related term are showing as below:

XSAT:CYCLE' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01   Med: 0.04   Max: 0.07
Current: 0.07

During the past 4 years, the highest Debt-to-Equity Ratio of Cyclezyme AB was 0.07. The lowest was 0.01. And the median was 0.04.

XSAT:CYCLE's Debt-to-Equity is ranked better than
82.54% of 1392 companies
in the Chemicals industry
Industry Median: 0.36 vs XSAT:CYCLE: 0.07

Cyclezyme AB Debt-to-Equity Historical Data

The historical data trend for Cyclezyme AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyclezyme AB Debt-to-Equity Chart

Cyclezyme AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
- - 0.01 0.07

Cyclezyme AB Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Debt-to-Equity - - 0.01 0.07

Competitive Comparison of Cyclezyme AB's Debt-to-Equity

For the Specialty Chemicals subindustry, Cyclezyme AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyclezyme AB's Debt-to-Equity Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Cyclezyme AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Cyclezyme AB's Debt-to-Equity falls into.


Cyclezyme AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Cyclezyme AB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.042 + 0.458) / 6.879
=0.07

Cyclezyme AB's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.042 + 0.458) / 6.879
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyclezyme AB  (XSAT:CYCLE) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Cyclezyme AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Cyclezyme AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyclezyme AB (XSAT:CYCLE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Cyclezyme AB (XSAT:CYCLE) » Definitions » Debt-to-Equity
Comparable Companies
Traded in Other Exchanges
N/A
Address
Scheelevagen 22, Lund, SWE, 223 63
Website
https://www.cyclezyme.se
Cyclezyme AB is a Sweden-based company that has developed an enzymatic platform focused on producing enzymes for green biochemical processes. This platform utilizes biotechnological methods to identify and improve enzymes capable of converting e.g. PET-based plastic materials for new building blocks. The company enables careful experiments and analyses of the behavior of different enzymes in the breakdown of e.g. PET material. The company refines its enzymes and also optimizes the processes for plastic recycling by combining experimental data with data analysis.

Cyclezyme AB (XSAT:CYCLE) Headlines

No Headlines